Institute for Safe Medication Practices launched new Vaccine Error Reporting Program
On Dec. 18, 2012, the Institute for Safe Medication Practices (ISMP) launched new Vaccine Error Reporting Program. Today,…
On Dec. 18, 2012, the Institute for Safe Medication Practices (ISMP) launched new Vaccine Error Reporting Program. Today,…
On Dec. 12, 2012, the FDA approved quadrivalent formulation of Fluarix (inactivated influenza vaccine; GlaxoSmithKline).
On Dec. 12, 2012, deCODE genetics announced an agreement whereby Amgen acquired deCODE Genetics, a global leader in…
On Nov. 28, 2012, USDA scientists working with an international team have completed a shotgun sequencing of the…
On Nov. 20, 2012, the FDA approved first seasonal influenza vaccine manufactured using cell culture technology (Flucelvax, Novartis).
On Nov. 20, 2012, the FDA approved a seasonal flu vaccine produced by Novartis using animal cell culture…
On Nov. 15, 2012, the U.S. Centers for Disease Control and Prevention (CDC) responded to the fungal meningitis…
On Nov. 14, 2012, scientists from the U.S., United Kingdom and Germany completed the first analysis of the…
On Nov. 8, 2012, Atossa Genetics, the Breast Health Companyï¾™ completed its IPO with gross proceeds of $4…
On Oct. 24, 2012, the Immunization Practices Advisory Committee (ACIP) voted to recommend that pregnant women receive a…
On Oct. 24, 2012, the Immunization Practices Advisory Committee (ACIP) voted to recommend use of HibMenCY (Menhibrix, GlaxoSmithKline),…
On Oct. 3, 2012, In 2012, Takeda Pharmaceutical acquired LigoCyte for an upfront payment of $60 million, with…
On Sept. 10, 2012, OHSU announced the estate of Garthe and Grace Brown designated more than $10 million…
On Sept. 10, 2012, the Albert and Mary Lasker Foundation announced winners of the 2012 Lasker Awards: Michael…
On Aug. 30, 2012, a new phlebovirus, discovered in northwestern Missouri by Dr. Scott Folk of Heartland Regional…
On Aug. 10. 2012, Genentech announced that Lucentisï¾® (ranibizumab injection) was approved by the FDA for treatment of…
On Aug. 3, 2012, GlaxoSmithKline announced that it has completed its acquisition of Human Genome Sciences for $3.6…
On Jul. 31, 2012, the Connecticut Development Authority was merged into Connecticut Innovations which was created by the…
On Jul. 29, 2012, the Serum Institute of India made its first International acquisition by acquiring Bilthoven Biologicals,…
On Jul. 12, 2012 the University of Kansas Cancer Center earned National Cancer Institute designation. Through efforts initially…
On Jul. 9, 2012, the NIH awarded $65 million grant to Institute for Translational Health Sciences to turn…
On Jul. 9, 2012, the FDA created the “Breakthrough Therapy Designation” that expedites development and review of drugs…
On Jun. 26, 2012, Roche announced it had closed the Nutley plant, established in 1929. The Nutley plant…
On Jun. 26, 2012, the U.S. Centers for Disease Control and Prevention (CDC) responded to a multi-state outbreak…
On Jun. 26, 2012, the U.S. Centers for Disease Control and Prevention (CDC) Advisory Committee on Immunization Practices…
On Jun. 25, 2012, the Helix Center Biotech Incubator opened its doors, owned and operated by the St….
On Jun. 25, 2012, the Rocky Mountain Biological Laboratory (RMBL) announced the unveiling of its Legacy Campaign, a…
On Jun. 24, 2012, the FDA approved HibMenCY (Menhibrix, GlaxoSmithKline), a new combination (meningococcal and Hib) vaccine for…
On Jun. 21, 2012, the European Region of the world was certified as polio-free.
On Jun. 15, 2012, Oxford University researchers announced that a knucklebone claimed to be of John the Baptist…